REJUVEN-EYES BIO-THERAPY

WHAT IS REJUVEN-EYES BIO-THERAPY?

WHY REJUVEN-EYES BIO-THERAPY?

HOW DOES REJUVEN-EYES BIO-THERAPY WORK?

WHAT ARE THE COMPONENTS IN REJUVEN-EYES BIO-THERAPY?

CONTACT FOR MORE INFORMATION

Rejuven-Eyes Bio-Therapy is a breakthrough, innovative, and painless new treatment – involving no surgery or intraocular injection – that is clinically proven to halt vision loss, even restore lost vision, in patients with Retinitis Pigmentosa, “dry” Macular Degeneration and Diabetic Retinopathy.

In each of these devastating eye conditions, light-sensitive “photoreceptor cells” in the eyes that are responsible for vision are damaged and even die, typically leading to irreversible vision loss.

However, if you have been diagnosed with any of these incurable eye conditions, we’re here to tell you –

There’s no need to lose hope.

That’s because Rejuven-Eyes Bio-Therapy :

  • Stops Ongoing Vision Loss After Just One Treatment Course

    This innovative therapy stopped ongoing vision loss quickly and painlessly in up to 80% of patients suffering from retinitis pigmentosa, dry macular degeneration, and diabetic retinopathy after just one course of treatment lasting 20 days.

  • Restores Lost Vision

    A significant proportion of patients reported a noticeable improvement in their eyesight on treatment with Rejuven-Eyes Bio-Therapy .

    Yes, it’s true – they regained some of their lost vision.

  • Is Clinically Proven to be 100% Safe

    Not a single patient reported any side effects or adverse reactions. In other words, clinical data based on patient outcomes clearly confirms that Rejuven-Eyes Bio-Therapy  is fast-acting, powerfully effective and 100% safe.

  • Does Not Involve Intraocular Injections

    This novel therapy is NOT injected directly into the eyes, but into the muscle like a flu shot. In fact, patients report that this treatment is comfortable and completely painless.

 

According to mainstream medicine, retinitis pigmentosa, dry macular degeneration, and diabetic retinopathy are incurable.

If you suffer from any of these eye conditions, nothing can prevent your vision loss from getting worse – or save your eyesight in the long run.

Retinitis Pigmentosa is a hereditary eye condition.

Patients – some as young as 17 years – typically experience a progressive loss of vision leading to “tunnel” vision. Finally, legal blindness results, with devastating consequences for the future lives of these patients.

No drug or treatment available today can prevent the complete loss of vision seen in retinitis pigmentosa.

Until now.

Incredibly, Rejuven-Eyes Bio-Therapy increased visual acuity and expanded the field of vision in patients with Retinitis Pigmentosa in preliminary clinical trials.

Some of these patients even regained their lost vision.

Note: visual acuity means clarity or sharpness of vision. 20/20 vision is normal vision. If you have 20/20 vision, you can see objects in clear detail at 20 feet which the average person can see at that distance.

Field of vision is the total area in which you can see with your entire eyesight when you focus your eyes on a single central point.

Dry Macular Degeneration affects central vision, color perception and the ability to see sharp images. It can progress unpredictably to the more dangerous “wet” or “neovascular” macular degeneration and crippling vision loss.

However, the vast majority of patients suffer from the dry form, which usually happens first.

So if dry macular degeneration can be detected and treated early, the chances of preventing vision loss and regaining healthy vision are very good.

Unfortunately, currently available therapies –

  • May halt ongoing vision loss in patients with wet macular degeneration, but are completely ineffective against dry macular degeneration.
  • Do nothing to heal the damaged photoreceptor cells in the retina, or prevent them from dying. In other words, the original retinal degeneration keeps progressing – so vision loss keeps getting worse.
  • Can be invasive, painful and damaging to vision.

No drug or treatment available today can slow vision loss – much less restore lost vision – in patients with dry macular degeneration.

Until now.

In preliminary clinical trials, Rejuven-Eyes Bio-Therapy was shown to increase visual acuity and expand field of vision in patients with Dry Macular Degeneration.

 Some of these patients also regained their lost vision.

Diabetic Retinopathy affects up to 80% percent of all people who have been suffering from either Type 1 or Type 2 diabetes for 10 years or more. The longer a person has diabetes, the higher their chances of developing this devastating eye condition.

Proper management of diabetes via a healthy lifestyle, diet, and medication may sometimes slow down progression of this eye condition – however, lost vision typically cannot be restored.

Until now.

Rejuven-Eyes Bio-Therapy has been shown to increase visual acuity and expand field of vision in patients with Diabetic Retinopathy as well.

In other words, if you have been diagnosed with Retinitis Pigmentosa, dry Macular Degeneration or Diabetic Retinopathy – you can save your vision with Rejuven-Eyes Bio-Therapy !

Online Contact Form  

 

In adult humans, the retina is 1/20th of a centimeter thick and is made up of 10 layers – including nerve fibers, photoreceptor cells, and many others.

Rejuven-Eyes Bio-Therapy is made up of eye-specific retinoprotective peptides that are capable of penetrating into and healing each of the ten layers of the retina.

As patients receive intramuscular (IM) injections daily during the 10-day treatment program, these potent peptides act upon each layer to heal damaged photoreceptor cells and strengthen vision.

These injections are not administered directly into the eye, but instead into muscle – just like a flu shot.

Before this revolutionary new therapy is given to patients with vision loss, they are tested to assess the status of their visual acuity and visual field. Once vision status is successfully diagnosed, the dose of Rejuven-Eyes Bio-Therapy is tailored according to each patient’s vision needs.

Treatment typically begins with IM injections twice a day for 10 days, followed by oral administration of a proprietary medication for 10 days. Each patient’s visual acuity and visual field are re-assessed on days 10 and 20 to monitor their progress.

As a result, Rejuven-Eyes Bio-Therapy:

  • Improves visual acuity – visual acuity means clarity or sharpness of vision. 20/20 vision is normal vision. If you have 20/20 vision, you can see objects in clear detail at 20 feet which the average person can see at that distance. If you have 10/20 vision, then you need to be as close as 10 feet to clearly see the objects that an average person with normal eyesight can see at 20 feet.
  • Expands the field of vision – the field of vision is the total area in which you can see with your entire eyesight when you focus your eyes on a single central point.

Rejuven-Eyes Bio-Therapy contains a number of carefully selected, synergistic small but therapeutically potent proteins – known as “retinoprotective” peptides that have been isolated and purified using proprietary techniques.

They prevent light-sensitive photoreceptor cells in the retina of the eyes from being damaged – and they also trigger the formation of new, healthy retinal photoreceptor cells. 

Because these peptides act to protect the retina, they are known as “retinoprotective” peptides.

Rejuven-Eyes Bio-Therapy contains the following retinoprotective peptides –

  • Retinalamin – This is a naturally occurring peptide complex that is originally isolated from the retina. It acts specifically on the eyes to improve overall retinal function. Retinalamin has also been shown to trigger formation of new retinal cells in laboratory experiments. In patient studies, Retinalamin significantly improved visual acuity and expanded the field of vision without causing any adverse reactions or complications.
  • Epitalon – This synthetic tetrapeptide has been shown to preserve the structure and functional activity of the retina in in a laboratory model of vision loss. Epitalon improved visual functions in up to 90% of treated patients with the symptoms of pigmented retinal degeneration that are typically seen in Retinitis Pigmentosa and other related eye conditions.
  • Other potent retinoprotective peptides.

Vision loss can tear your life apart. It can destroy your independence and your ability to determine your own future.

If you have been diagnosed with Retinitis Pigmentosa, Dry Macular Degeneration or Diabetic Retinopathy − then the harsh reality is that neither your eye doctor, nor any of the drugs or treatments available today can save your vision.

However, there’s no need to lose hope.

Rejuven-Eyes Bio-Therapy has been shown to –

  • Quickly and painlessly stop progression of vision loss in patients with retinitis pigmentosa, dry macular degeneration, and retinitis pigmentosa after just one course of treatment lasting 20 days!
  • Restore lost vision in a significant proportion of patients,
  • Without causing any side effects or adverse reactions in a single patient.

So if you are suffering from one of these 3 devastating eye diseases, or if you know someone who does –

We strongly recommend that you get in touch with us right away to learn how Rejuven-Eyes Bio-Therapy can prevent further damage to your precious vision, perhaps even restore your lost vision!

CONTACT FOR MORE INFORMATION